Ghent University Academic Bibliography

Advanced

Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin β therapy

Stijn Jonckheere UGent, Jan Dierick, Hilde Vanhouteghem, Mieke Devleeschouwer and Veronique Stove UGent (2010) ACTA HAEMATOLOGICA. 124(1). p.27-33
Please use this url to cite or link to this publication:
author
organization
alternative title
Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin beta therapy
year
type
journalArticle (original)
publication status
published
subject
keyword
Reticulocyte hemoglobin content, CHRONIC KIDNEY-DISEASE, Continuous erythropoietin receptor activator, Hypochromic red blood cells percentage, Dialysis, Epoetin beta, RECOMBINANT-HUMAN-ERYTHROPOIETIN, RETICULOCYTE HEMOGLOBIN, ANEMIA, METABOLISM, MANAGEMENT, CERA, DEFICIENCY, GUIDELINES, PARAMETER
journal title
ACTA HAEMATOLOGICA
Acta Haematol.
volume
124
issue
1
pages
27 - 33
Web of Science type
Article
Web of Science id
000280461600007
JCR category
HEMATOLOGY
JCR impact factor
1.316 (2010)
JCR rank
56/65 (2010)
JCR quartile
4 (2010)
ISSN
0001-5792
DOI
10.1159/000313785
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
2129995
handle
http://hdl.handle.net/1854/LU-2129995
date created
2012-06-03 16:53:44
date last changed
2016-12-19 15:39:21
@article{2129995,
  author       = {Jonckheere, Stijn and Dierick, Jan and Vanhouteghem, Hilde and Devleeschouwer, Mieke and Stove, Veronique},
  issn         = {0001-5792},
  journal      = {ACTA HAEMATOLOGICA},
  keyword      = {Reticulocyte hemoglobin content,CHRONIC KIDNEY-DISEASE,Continuous erythropoietin receptor activator,Hypochromic red blood cells percentage,Dialysis,Epoetin beta,RECOMBINANT-HUMAN-ERYTHROPOIETIN,RETICULOCYTE HEMOGLOBIN,ANEMIA,METABOLISM,MANAGEMENT,CERA,DEFICIENCY,GUIDELINES,PARAMETER},
  language     = {eng},
  number       = {1},
  pages        = {27--33},
  title        = {Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin \ensuremath{\beta} therapy},
  url          = {http://dx.doi.org/10.1159/000313785},
  volume       = {124},
  year         = {2010},
}

Chicago
Jonckheere, Stijn, Jan Dierick, Hilde Vanhouteghem, Mieke Devleeschouwer, and Veronique Stove. 2010. “Erythrocyte Indices in the Assessment of Iron Status in Dialysis-dependent Patients with End-stage Renal Disease on Continuous Erythropoietin Receptor Activator Versus Epoetin β Therapy.” Acta Haematologica 124 (1): 27–33.
APA
Jonckheere, Stijn, Dierick, J., Vanhouteghem, H., Devleeschouwer, M., & Stove, V. (2010). Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin β therapy. ACTA HAEMATOLOGICA, 124(1), 27–33.
Vancouver
1.
Jonckheere S, Dierick J, Vanhouteghem H, Devleeschouwer M, Stove V. Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin β therapy. ACTA HAEMATOLOGICA. 2010;124(1):27–33.
MLA
Jonckheere, Stijn, Jan Dierick, Hilde Vanhouteghem, et al. “Erythrocyte Indices in the Assessment of Iron Status in Dialysis-dependent Patients with End-stage Renal Disease on Continuous Erythropoietin Receptor Activator Versus Epoetin β Therapy.” ACTA HAEMATOLOGICA 124.1 (2010): 27–33. Print.